Stage 3 Neuroanaesthesia / Advanced Neurocritical Care
Last modified on March 29th, 2022
14.8.3 Applies the principles of shared decision making about the suitability of surgery and anaesthesia with high-risk patients and colleagues.
14.9.2 Applies understanding of co-morbidities in patients requiring general anaesthesia and delivers management strategies to offer individualised care.
HiLLO 12: Doctors specialising in Intensive Care Medicine understand the special needs of, and are competent to manage patients with neurological diseases, both medical and those requiring surgery, which will include the management of raised intracranial pressure, central nervous system infections and neuromuscular disorders.
SSM NICU: Can recognise, resuscitate and initiate treatment of the patient with acute neurological injury, having an enhanced understanding of the specific neuropathophysiologies. They will be able to institute advanced pharmacological and physical therapeutic interventions, and continue ongoing diagnostic and disease management strategies, including multi-organ support.
Please note the following two resources may require a personal login
Neuromuscular disorders and anaesthesia. Part 1: generic anaesthetic management Continuing Education in Anaesthesia Critical Care & Pain,
The management of patients with ventilatory insufficiency due to neuromuscular disease should follow BTS/ICS guidelines.
The management of decompensated acute inflammatory neuropathy should follow best practice guidance.
We are keen that this resource stays up-to-date, therefore if you find any links that are no longer working please let us know. Similarly, we will aim to review the resources at least yearly, incorporating new trials or review articles as well as relevant web resources.
If you have a suggestion for a resource that is not listed please specify your suggestions using our online form and we will consider it for review.